ARK Invest has been the talk of Wall Street over the last couple of years, outperforming the market and solidifying its place among the big players in the investments world. Cathie Wood is the founder and head of this investment house, and many have compared her rising star to the likes of Warren Buffett.
With famous investors and huge brokerage firms, many traders are looking to mirror their plays to capitalize on the gains that the big dogs are making. Lucky for us, ARK Invest releases its trades on a daily basis at the end of the trading day.
While some companies would require a subscription service or monetary fee to see what makes ARK Invest tick, here at 24/7 Wall St. we would rather give you the data for free. Here’s a quick look at some of the major trades that ARK Invest executed on April 5, 2021.
The ARK Fintech Innovation ETF (NYSEARCA: ARKF) deals mainly with up-and-coming fintech stocks as the name suggests. Some of its biggest holdings include the likes of Square, Zillow, Pinterest, PayPal, and Alibaba. Net assets for the fund are currently $4.4 billion. Here are a couple of trades we would highlight in this fund: NO BUYS OR SELLS
ARK Genomic Revolution ETF (NYSEARCA: ARKG) looks at companies across multiple industries but the general focus is on Health Care and companies that are changing the game technologically in this field. Some of the biggest holdings include the likes of Pacific Biosciences, Teladoc Health, CRISPR and Fate Therapeutics. Net assets for the fund are currently $10.6 billion. Here are a couple of trades we would highlight in this fund: Buy 316,100 shares of Butterfly Network, Buy 70,299 shares of Signify Health, & Sell 68,057 shares of Syros Pharma.
ARK Innovation ETF (NYSEARCA: ARKK) has a particular focus on disruptive innovation and it spans across multiple industries but the focus is primarily tech. Some of the biggest names are in this fund like Telsa, Roku, Square, Zillow and Spotify. Net assets for this fund are currently $23.5 billion. Here are a couple of trades we would highlight in this fund: Buy 28,605 shares of 10x Genomics, Buy 266,865 shares of Twitter, & Buy 72,622 shares of Beam Therapeutics.
ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) is focused on companies that are in the field of autonomous technology and robotics, specifically ones that are disruptively innovating. More big names in this fund include Tesla, Alphabet, JD.com, Baidu and Iridium. Net assets for this fund are currently $3.65 billion. Here are a couple of trades we would highlight in this fund: NO BUYS OR SELLS
ARK Next Generation Internet ETF (NYSEARCA: ARKW) this fund is focused on companies that are disruptively innovating within the theme of the next generation of the internet. There are some similar names in this fund as the others including Tesla, Square, Grayscale Bitcoin Trust, Facebook, and Snap. Net assets for this fund are currently $8.2 billion. Here are a couple of trades we would highlight in this fund: Buy 75,881 shares of Sea & Sell 212,554 shares of Tencent.
Check out all of the trades here:
Fund | Direction | Ticker | Company | Shares |
---|---|---|---|---|
ARKG | Buy | BFLY | BUTTERFLY NETWORK INC | 316,100 |
ARKG | Buy | MASS | 908 DEVICES INC | 21,256 |
ARKG | Buy | RPTX | REPARE THERAPEUTICS INC | 2,000 |
ARKG | Buy | SGFY | SIGNIFY HEALTH INC | 70,299 |
ARKG | Sell | PHR | PHREESIA INC | 22,100 |
ARKG | Sell | PSTI | PLURISTEM THERAPEUTICS INC | 23,726 |
ARKG | Sell | SYRS | SYROS PHARMACEUTICALS INC | 68,057 |
ARKK | Buy | TXG | 10X GENOMICS INC | 28,606 |
ARKK | Buy | TWTR | TWITTER INC | 266,865 |
ARKK | Buy | TRMB | TRIMBLE INC | 19,346 |
ARKK | Buy | FATE | FATE THERAPEUTICS INC | 31,423 |
ARKK | Buy | BEAM | BEAM THERAPEUTICS INC | 72,622 |
ARKW | Buy | SE | SEA LTD | 75,881 |
ARKW | Sell | TCEHY | TENCENT HOLDINGS LTD | 212,554 |
Catherine Wood, the CEO and CIO of ARK Investment Management LLC is a minority and non-voting shareholder of 24/7 Wall St., LLC, owner of a673b.bigscoots-temp.com.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.